Position in ARVN
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$19,536
-$12,635 QoQ
Shares Held
2,351
-22.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#157
of 201 holders
Holding Since
Jun 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ARVN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Tower Research Capital LLC (TRC) holds $49,479,230 across 466 Biotechnology names. ARVN ranks #249 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARGX |
Argenx SE
|
4,547 | $4,218,570 | |
| 2 | BBIO |
BridgeBio Pharma, Inc.
|
38,206 | $2,845,582 | |
| 3 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
34,537 | $2,815,110 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
4,292 | $2,131,964 | |
| 5 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
3,927 | $2,108,602 | |
| 6 | AXSM |
Axsome Therapeutics, Inc.
|
6,437 | $1,575,584 | |
| 7 | INSM |
INSMED Inc
|
10,927 | $1,165,036 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
32,746 | $1,158,880 |
All Filings in ARVN
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $19,536 | 2,351 | Shares | Defined | 2026-08-11 | |
| 2026-03-31 | $32,171 | 3,035 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $36,647 | 3,090 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $63,967 | 7,508 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $42,827 | 5,819 | Shares | Defined | 2025-08-15 | |
| 2025-03-31 | $6,907 | 984 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $159,206 | 8,305 | Shares | Defined | 2025-02-13 | |
| 2024-09-30 | $210,930 | 8,564 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $152,079 | 5,713 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $35,789 | 867 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $276,800 | 6,725 | Shares | Other | 2024-02-13 | |
| 2023-09-30 | $67,914 | 3,458 | Shares | Other | 2023-11-14 | |
| 2023-06-30 | $235,317 | 9,481 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $144,959 | 5,306 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $115,287 | 3,370 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $273,034 | 6,137 | Shares | Other | 2022-11-10 | |
| 2022-06-30 | $116,167 | 2,760 | Shares | Other | 2022-08-15 | |
| 2022-03-31 | $28,736 | 427 | Shares | Other | 2022-05-12 | |
| 2021-12-31 | $50,926 | 620 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $152,607 | 1,857 | Shares | Other | 2021-11-15 | |
| 2021-06-30 | $224,917 | 2,921 | Shares | Other | 2021-08-16 | |
| 2021-03-31 | $420,461 | 6,361 | Shares | Other | 2021-05-17 | |
| 2020-12-31 | $101,661 | 1,197 | Shares | Defined | 2021-02-16 | |
| 2020-09-30 | $385,739 | 16,338 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $95,018 | 2,833 | Shares | Defined | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||